analysis undertaken in the United Kingdom healthcare system. 7, 8 Addressing this omission by quantifying the economic costs associated with this complication, the efforts to reduce infection by devices, medical treatments, and pathways can be justified and contextualized.
The Wound in Open Lower Limb Fracture (WOLLF) trial sought to assess the effectiveness of negative-pressure wound therapy (NPWT) in patients with open fractures of the lower limb. 9 Negative-pressure wound therapy is a system used to manage the soft-tissue defects associated with open fracture, among other indications. A major part of the trial examined the cost-effectiveness as well as the clinical effectiveness of the device. This involved collecting detailed information pertaining to complications, ongoing treatment and care needs. The trialbased health economic analysis collected data on economic costs to the health and social care systems and to patients, as well as data on preference-based health-related quality-of-life measures recommended for cost-effectiveness purposes. This study used these trial data to explore the health economic implications of deep infection after open fracture.
Patients and Methods
This study used data from the WOLLF study, a prospective, randomized, controlled trial embedded in the United Kingdom Major Trauma Network. The design and methods of WOLLF are described in detail elsewhere. 10 Briefly, the trial recruited adult patients with open fractures of the lower limb graded as Gustilo-Anderson 11 two or above, all of whom were treated in a United Kingdom Major Trauma Centre or Trauma Unit with joint orthopaedic and plastic surgical care.
11 Patients were stratified by centre and Gustilo-Anderson grade.
The data set used for this secondary analysis included all 460 participants in the WOLLF study, regardless of trial allocation. Two groups of patients were compared: those without, and those with, a diagnosis of deep surgical site infection (SSI), according to the Centres for Disease Control (CDC) definition.
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This definition covers infection occurring within 30 days of surgery, unless an implant is in place, in which case this period is extended to 12 months. Deep SSI presenting within 12 months of injury and any wound infection requiring continuing medical or surgical intervention after 30 days, including those leading to amputation, were also recorded as a deep SSI. In the WOLLF study, wounds were assessed and medical records reviewed at hospital discharge or, in the case of discharge before 30 days, at the first outpatient appointment (between 30 days and six weeks post-injury in line with routine care in the United Kingdom). Wounds were assessed in person and research staff recorded the characteristics of any infection.
Two sets of long-term economic consequences were measured within the WOLLF study: preference-based health-related quality-of-life outcomes and economic costs. Two quality-of-life instruments were used, namely the EuroQol EQ-5D-3L and the 6-Item Short-Form Health Survey questionnaire (SF-6D), based on participant completion of the EQ-5D-3L and 12-Item Short-Form Health Survey questionnaire (SF-12) measures at baseline and at three, six, nine, and 12 months post-randomization. 13, 14 Responses to the EQ-5D-3L descriptive system covering five dimensions (mobility, self-care, usual activities, pain, and anxiety/depression), each with three severity levels (no problems, some or moderate problems, and severe or extreme problems), were converted into health utility scores at each time point using the Dolan 15 United Kingdom algorithm. Responses to the SF-12 descriptive system covering eight health concepts (physical functioning, physical role limitations, bodily pain, general health, vitality, social functioning, emotional role limitations, mental health) were converted into SF-6D health utility scores at each timepoint using the Brazier and Roberts 16 United Kingdom algorithm. Using each measure, quality-adjusted life-year (QALY) profiles were generated for each participant over the one-year follow-up period, calculated as the area under the curve with linear interpolation. QALYs provide a "measure of the state of health of a person or group in which the benefits, in terms of length of life, are adjusted to reflect the quality of life. One QALY is equal to one year of life in perfect health". 17 Economic costs were calculated using participant-completed questionnaires at each timepoint and encompassed use of hospital inpatient services, hospital outpatient services, community health and social care, medication use, and aids and adaptations. Resource inputs were valued using primary and secondary cost sources. Costs were calculated for the initial period of hospitalization, the period between hospital discharge and three months post-randomization, and subsequently for each three-month time period up to one-year post-randomization. Cumulative total costs were calculated from an NHS and personal social services (PSS) perspective in accordance with national methodological guidance. 18 Costs are reported in British pounds sterling (£), using 2015 prices. Statistical analysis. Differences at each timepoint in mean utility values and mean NHS and PSS costs, and differences in EQ-5D-3L and SF-6D-derived QALYs and cumulative NHS and PSS costs for the one-year follow-up period, were estimated using Student's t-tests. Linear regression models were estimated using ordinary least squares (OLS), with total NHS and PSS costs over each follow-up period regressed on age, gender, trial site, Gustilo-Anderson wound grade, presence of diabetes, height, weight, and smoking status. While age and gender are standard controls, trial site was included to capture any differences in treatment between trial sites, wound grade was included to capture differences in the severity of the injury, and the remaining covariates were included to capture potential differences in immune response that may regulate the impact of deep SSI. The same set of covariates was used with QALY estimates as the dependent variables, but with additional controls for baseline health utility values. The OLS estimator was selected in preference to a generalized linear model with alternative distributional families and link functions on the basis of Akaike information criterion statistics. 19 The baseline analysis was completed using multiply imputed data, with a complete case analysis included as a sensitivity analysis. A p-value < 0.05 denoted statistical significance. Statistical analysis was conducted using Stata 15 (StataCorp, College Station, Texas) and R. comprised 460 individuals, 35 of whom had deep SSI, 423 of whom did not, and two patients for whom data were missing. In the deep SSI group, the mean was 45 years, compared with 43 years in those without deep SSI. Male patients comprised 74% of each group. The proportion of those with diabetes was slightly higher in those with deep SSI, at 11% versus 5% in those without. There was also a higher proportion of smokers in the deep SSI group, 46% versus 31% in those without (Table I) . Supplementary Table i summarizes the mean EQ-5D utility scores and SF-6D utility scores for each group, at each timepoint, and reports tests of statistical significance for differences between mean utility scores in each group. Similarly, QALYs calculated over the one-year follow-up period (using either EQ-5D or SF-6D utility scores) and NHS and PSS costs over each time period (initial hospitalization and subsequent period to three months post-randomization, three to six months, six to nine months, nine to 12 months, zero to 12 months) and for each cost category (hospital inpatient care, hospital outpatient care, community health and social care, medications, aids and adaptations) are reported together with tests of statistical significance for differences in their values. Differences were found between EQ-5D-3L utility scores at six months (0.14 higher in those without deep SSI; p = 0.038, two-sample t-test), 12 months (0.16 higher in those without deep SSI; p = 0.023, two-sample t-test), as well as in EQ-5D-3L QALYs calculated over the one-year follow-up period (0.16 higher in those without deep SSI; p = 0.01, two-sample t-test). These results were not, however, replicated in the SF-6D assessment.
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Results
Regarding economic costs, mean hospital inpatient costs in the three-to-six-month time period were higher in the deep SSI group, at £2692 (£0 to £21 629) versus £691 (£0 to £10 651; p = 0.049, two-sample t-test). Mean total NHS and PSS costs were higher in the deep SSI group over the zero-to-six-month time period, at £15 598 (£5237 to £41 487) versus £12 304 (£4044 to £39 655; p = 0.099, two-sample t-test), and the threeto-six-month time period, at £3542 (£328 to £25 717) versus £1597 (£45 to £18 601; p = 0.095, two-sample t-test). Mean total NHS and PSS costs were, however, higher in the group without deep SSI in the six-to-nine-month time period, at £1091 (£0 to £26 580) versus £623 (£0 to £15 499; p = 0.068, two-sample t-test). Table II details the results of the multivariate analyses based on multiple imputation of missing data, considering the effects of deep SSI on total NHS and PSS costs over each follow-up period, as well as on QALYs calculated using either EQ-5D-3L or SF-6D utility scores over the one-year follow-up period. Using multiply imputed data, there was a statistically significant difference in QALYs calculated using EQ-5D-3L utility scores (p = 0.047). Results based on analysis of complete cases are presented in Supplementary Table ii. In the complete case analysis, deep SSI was not a statistically significant predictor of a difference in QALYs calculated using the EQ-5D-3L (p = 0.079). For both the multiple imputation and complete case analyses, deep SSI was not found to have a statistically significant association with total NHS and PSS costs over any of the time periods considered or with SF-6D generated QALYs calculated over the one-year follow-up period.
Discussion
To our knowledge, this is the first study to assess the economic outcomes associated with deep surgical site infection in patients with an open fracture of the lower limb. The use of high-quality, prospectively collected data is a major strength of this study. This is particularly relevant to populations of patients with open fractures, who typically have poor long-term follow-up rates in research studies. 21, 22 Another major strength is the multicentre recruitment of patients, thereby improving the generalizability of the study's findings across healthcare settings, particularly within the NHS.
The total number of patients with deep surgical site infection (n = 35) is relatively small. This means that the summative analyses here can be influenced by a few clinical events or treatments. Furthermore, follow-up is limited to 12 months. Other studies have shown that the consequences of complications after open fracture persist well beyond 12 months, 23 and therefore our estimates can be viewed as conservative assessments of the long-term economic implications of deep surgical site infection in patients with an open fracture of the lower limb.
Other studies have considered complications following lower limb injury. MacKenzie et al 8 studied over 500 major injuries of the lower limb and assessed the cost implications as part of the Lower Extremity Assessment Project (LEAP). The LEAP patient cohort was similar to the WOLLF cohort but was not limited to open fractures. The LEAP analysis was, however, undertaken only from the perspective of the healthcare provider. 8 In turn, the healthcare context for the LEAP analysis is very different to the NHS and no specific economic analysis was undertaken of the subgroup of patients with infection. The LEAP findings have been replicated in other studies of severe lower limb injury.
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In our study, there was a statistically significant difference in EQ-5D-3L QALYs generated over the one-year follow-up period. While this finding was not replicated for the SF-6D, the overall difference in SF-6D utility score at 12 months exceeds the 0.03 minimally important clinical difference.
24 Unsurprisingly, economic costs were higher in the deep SSI group at 12 months. These costs were borne both by the NHS and social care systems and by patients and their carers. The difference in total NHS and PSS costs over the 12-month follow-up period was estimated at £1242. This figure may be of benefit to clinical and budgetary service planning. More generally, the economic estimates generated by this analysis can act as data inputs into future economic evaluations of preventive or treatment interventions.
In conclusion, the entirely expected finding of higher economic costs within the deep infection cohort should empower the clinician to be thorough in identifying infection expeditiously and being as rigorous as possible in reducing its incidence. When viewed in conjunction with our findings on preference-based health-related quality-of-life outcomes, our estimates are important also for counselling patients that deep surgical site infection in open fractures of the lower limb will have considerable long-term consequences, through which they will need significant support.
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Take home message -Deep surgical site infection in patients with an open fracture of the lower limb may lead to significantly impaired health-related quality of life and increased economic costs.
-Our economic estimates are important for the patient, who can now be informed that deep surgical site infection in open fractures of the lower limb will have considerable long-term consequences through which they will need significant support.
Supplementary material (available online)
Tables showing descriptive statistics of economic outcomes at each follow-up point and separate results of multivariate analyses based on complete cases.
